SCHEMBL1584416

SCHEMBL1584416

CC(C)(C)OC(=O)NCCOCCNC(=O)C(C)(C)Oc1ccc(C(=O)c2ccc(Cl)cc2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 9/20 0.52
PPARG P37231 4/20 0.52
FABP2 P12104 2/20 0.52
SLC22A12 Q96S37 1/20 0.52
SMN1; SMN2 Q16637 3/20 0.48
MAPT P10636 3/20 0.48
ALDH1A1 P00352 3/20 0.48
USP2 O75604 2/20 0.48
POLB P06746 2/20 0.48
HTT P42858 1/20 0.48
CYP1A2 P05177 3/20 0.47
CYP3A4 P08684 3/20 0.47
CYP2C19 P33261 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
LMNA P02545 2/20 0.47
CYP2C9 P11712 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
ABCB11 O95342 1/20 0.47
ADORA3 P0DMS8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1584689 0.93 PPARA (0.56) PPARAPPARGFABP2SLC22A12SMN1; SMN2
SCHEMBL22221443 0.91 PPARA (0.54) PPARAPPARGFABP2SLC22A12SMN1; SMN2
SCHEMBL1583983 0.88 PPARA (0.51) PPARAPPARGFABP2SLC22A12SMN1; SMN2
SCHEMBL12707617 0.88 PPARA (0.51) PPARAPPARGFABP2SLC22A12SMN1; SMN2
SCHEMBL1584243 0.88 PPARA (0.59) PPARAPPARGFABP2SLC22A12SMN1; SMN2
SCHEMBL1584473 0.87 ALDH1A1 (0.54) PPARAPPARGFABP2SMN1; SMN2MAPT
SCHEMBL12707622 0.87 PPARA (0.50) PPARAPPARGFABP2SLC22A12SMN1; SMN2
SCHEMBL1584444 0.87 PPARA (0.50) PPARAPPARGFABP2SLC22A12SMN1; SMN2
SCHEMBL1584385 0.87 PPARA (0.54) PPARAPPARGFABP2SLC22A12SMN1; SMN2
SCHEMBL12707625 0.86 PPARA (0.53) PPARAPPARGFABP2SLC22A12SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011044141-A1 FATTY ACID FIBRATE DERIVATIVES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. (US) 2011-04-14 WO disclosed
US-20110082210-A1 FATTY ACID FIBRATE DERIVATIVES AND THEIR USES CATABASIS PHARMACEUTICALS, INC. 2011-04-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110082210-A1 FATTY ACID FIBRATE DERIVATIVES AND THEIR USES FABP1, PPARA, FABP4 PPARA 2/4885PPARG 6/4885FABP2 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.